Are US Tech Bulls Missing the Small Cap Rotation? Microcaps Outperform as Index Giants Stall

There’s a certain poetic justice in watching the so-called “Mag 7” of US tech stocks morph from market darlings to dead weight. For years, the narrative was simple: just buy the biggest, most liquid names and let the algos do the rest. But as the June dust settles, a new rotation is underway, one that’s catching most of the ETF crowd flat-footed. Small and microcaps are quietly staging a comeback, and if you’re still glued to your XLK screens, you might be missing the only real action left in US equities.

Let’s start with the scoreboard. The S&P 500’s largest constituents (the Mag 7) have gone from driving 80% of the index’s returns to dragging it into the mud. According to Seeking Alpha’s June 27th report, small and microcaps are now outperforming large caps, signaling a durable rotation after years of underperformance. Healthcare and REITs are attracting bargain hunters, but the real story is in the microcap space, where price discovery is alive and well. XLK, the tech ETF, is stuck at $184.83, dead flat, with no pulse. The Mag 7 now command roughly 34% of the S&P 500 and 38% of the QQQ, making every tick in the index a referendum on their collective fate. But what happens when the crowd starts to look elsewhere?

The context is brutal. Tech stocks just closed out a volatile week sharply lower, as per YouTube’s “Tech Slump Deepens” segment. Investors are finally reassessing the sustainability of the AI trade, with concerns over rising semiconductor inventories and the end of easy money. The AI-fueled rally that turbocharged the market in 2025 has run headlong into the brick wall of valuation reality. Abby Joseph Cohen, speaking on Bloomberg Money, warns that lofty stock prices may be hiding risks that will only become apparent when liquidity dries up. Meanwhile, the Fed’s new chair, Kevin Warsh, is signaling a more pragmatic, less market-coddling approach than Greenspan ever did. Translation: don’t expect a dovish put when the next downdraft hits.

But here’s where it gets interesting. While the big names stagnate, capital is trickling down the market cap spectrum. Microcaps, long the domain of day traders and masochists, are suddenly outperforming. The Russell Microcap Index is up 4.2% month-to-date, while the S&P 500 is treading water. Healthcare and REITs are seeing inflows, but the real juice is in the microcap space, where price discovery is alive and well. This isn’t just a dead cat bounce. The breadth is improving, and the relative strength index (RSI) for microcaps has broken above 60 for the first time since 2022. The message is clear: the market is hunting for growth in places the quant funds forgot.

The historical parallels are hard to ignore. Every major bull market has ended with a rotation out of the leaders and into the laggards. In 2000, it was the dot-coms giving way to industrials. In 2007, it was financials rolling over as energy rallied. Today, it’s the Mag 7 losing steam while microcaps quietly outperform. The difference this time is the scale. With passive flows still dominating, the rotation is slower, but it’s happening. The last time microcaps outperformed large caps for more than a quarter, the S&P 500 spent the next year chopping sideways while the Russell 2000 posted double-digit gains.

The technicals are telling. XLK is stuck at $184.83, with a 20-day moving average that’s as flat as the yield curve. The Mag 7 are all below their 50-day moving averages, and breadth is improving for the first time in months. The Russell Microcap Index has broken out above its 200-day moving average, and the advance-decline line is finally ticking higher. This is a classic rotation, quiet, but persistent.

Strykr Watch

For traders, the setup is clear. XLK is dead money until it can reclaim $190, with support at $180. The Mag 7 are in purgatory, and every failed rally is an invitation for more rotation. The Russell Microcap Index is the one to watch: support at 1,200, resistance at 1,260. RSI is at 62, signaling momentum is building. Healthcare and REITs are the stealth winners, with XLV and VNQ both breaking above key resistance levels. If the rotation holds, microcaps could outperform for the rest of the summer.

Volatility is subdued in the large caps, but microcap volatility is ticking higher. Implied volatility on the Russell Microcap Index is at 24%, up from 18% last month. This isn’t panic, this is opportunity. The market is finally rewarding stock pickers and punishing index huggers.

The risks are obvious. If the Mag 7 stage a comeback, the rotation could reverse in a heartbeat. Liquidity in microcaps is always a concern, and a macro shock could send the whole space back to the penalty box. But for now, the momentum is real, and the risk-reward is skewed in favor of the nimble.

The opportunity is clear: long microcaps on dips, short XLK on rallies. This is a trader’s market, not an investor’s market. The days of buying the index and going to the beach are over, at least for now.

Strykr Take

The Mag 7 may still dominate the headlines, but the real action is in the microcaps. This is the kind of rotation that only happens once every few years, and the early movers are already cashing in. For traders willing to do the work, the opportunity is real. For everyone else, it’s time to stop watching XLK and start hunting for alpha where the crowd isn’t looking.

As of 2026-06-28, the rotation is on. Don’t get left holding the bag when the music stops.